newsfilter
← Latest News
PR Newswire·

Mycrodose Therapeutics and Nova Mentis Announce LOI to Co-Develop Advanced Drug Delivery System

Partnership will Create Patented Products for the Treatment of Neuroinflammatory Disorders VANCOUVER, BC, Oct. 19, 2021 /PRNewswire/ - October 19, 2021 – Nova Mentis Life Science Corp. (CSE:NOVA) (FSE: HN3Q) (OTCQB:NMLSF) ("NOVA" or the "Company"